Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia | Clinical Trials | Clareo Health

Back to search

WITHDRAWNPhase 3

Lactobacillus Lozenges as Preventative Care in Low-grade Dysplasia

NCT05707702•Boston Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Low-grade Oral Dysplasia

Interventions

Probiotic oral lozenges

Standard of care for oral dysplasia

Locations

United States

Locations (1)

Boston Medical Center

Boston, Massachusetts, United States

Key Dates

Start Date

April 29, 2024

Primary Completion Date

November 1, 2025

Completion Date

November 1, 2025

Last Updated

May 1, 2024

Sponsors

Lead Sponsor

Boston Medical Center

Collaborators

University of Alabama at Birmingham

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions